文献速递炎症性肠病消化道肿瘤与早癌

肛周克罗恩病与不良疾病结局相关:一项基于epiIIRN队列的全国性研究

Perianal Crohn's Disease Is Associated With Poor Disease Outcome: A Nationwide Study From the epiIIRN Cohort.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-04-09

该研究基于epiIIRN队列中12,904例克罗恩病患者,探讨肛周受累情况及严重与非严重肛周克罗恩病的病程差异。结果显示肛周克罗恩病患病率随时间累积,且与住院、手术及肛管直肠癌风险增加相关,严重肛周病变结局更差。

要点

  • 肛周克罗恩病患病率在诊断后1、3、5、10年分别为7.9%、9.4%、10.3%、11.6%。
  • 5年时肛周克罗恩病患者住院率64% vs 无肛周病变36%,手术率38% vs 9%。
  • 严重肛周克罗恩病住院率73% vs 非严重61%,手术率43% vs 35%。

核心结论

  • 尽管免疫调节剂和生物制剂使用增加,肛周克罗恩病仍与不良疾病结局相关,尤其严重肛周病变。

研究设计与样本

  • 基于epiIIRN队列的全国性研究,纳入以色列两家健康维护组织覆盖78%人口,共12,904例克罗恩病患者(2005年起始队列,儿童起病2,186例占17%),随访86,119人年。

主要发现

  • 肛周克罗恩病诊断1530例(12%),其中严重肛周克罗恩病574例(4%)。
  • 肛周克罗恩病患病率在诊断后1、3、5、10年分别为7.9%、9.4%、10.3%、11.6%。
  • 5年时肛周克罗恩病患者住院率64% vs 无肛周病变36%(P < .001),炎症性肠病相关手术率38% vs 9%(P < .001),肛管直肠癌发生率4.2/10,000人年 vs 1.2/10,000人年(P = .01)。
  • 严重肛周克罗恩病对比非严重肛周克罗恩病:住院率73% vs 61%(P = .004),手术率43% vs 35%(P = .001)。

临床怎么用

  • 临床应重视克罗恩病患者的肛周病变评估,尤其严重肛周病变者需警惕住院、手术及肛管直肠癌风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Limited population-based data have explored perianal involvement in Crohn's disease (CD) and compared the disease course between severe and non-severe perianal CD (PCD). We aimed to explore the disease course of these phenotypes in a population-based study of CD. METHODS: Cases were identified from the epi-IIRN cohort and included 2 Israeli health maintenance organizations covering 78% of the population. We validated specific algorithms to identify fistulizing PCD and to differentiate severe from non-severe disease by medication utilization, International Classification of Disease, 9th Revision codes, and perianal procedures. RESULTS: A total of 12,904 CD patients were included in an inception cohort from 2005 (2186 pediatric-onset, 17%) providing 86,119 person-years of follow-up. Fistulizing PCD was diagnosed in 1530 patients (12%) (574 with severe PCD, 4%). The prevalence of PCD was 7.9%, 9.4%, 10.3%, and 11.6% at 1, 3, 5, and 10 years from CD diagnosis, respectively. At 5 years, PCD patients were more likely to be hospitalized (36% in non-PCD vs 64% in PCD; P < .001), undergo inflammatory bowel disease-related surgeries (9% vs 38%, respectively; P < .001), and develop anorectal cancer (1.2/10,000 person-years for non-PCD vs 4.2/10,000 for PCD; P = .01). Severe PCD was associated with poorer outcomes compared with non-severe PCD, as shown for hospitalizations (61% in non-severe PCD vs 73% in severe; P = .004) and surgeries (35% vs 43%; P = .001). CONCLUSIONS: Despite higher utilization of immunomodulators and biologics, PCD is associated with poor disease outcomes, especially in severe PCD.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Atia O, Asayag N, Focht G, et al. Perianal Crohn's Disease Is Associated With Poor Disease Outcome: A Nationwide Study From the epiIIRN Cohort. Clin Gastroenterol Hepatol. 2021. PMID: 33845216. doi:10.1016/j.cgh.2021.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。